BEAM had a nice bullish breakout in today's pre-market session, consolidating in the intraday and show signals of a continuation to retest that $22.74 and push on up into the next range with previous resistance being $28.48.
This comes after announcing FDA Regenerative Medical Status for BEAM-101 to treat Sickle Cell Disease 2 weeks ago.
This comes after announcing FDA Regenerative Medical Status for BEAM-101 to treat Sickle Cell Disease 2 weeks ago.
Trade active
BEAM is trading to the higher side of the Support Trend and is currently on track to retest the $22.75. We had a double-top the last time we retested that $22.75, so if we make it and are able to break above/find support, then our $28 Price Target may not be such a pipe dream. #MyMIWallet #BEAM
Tim Burks | Founder - MyMI Wallet
Empower your finances with our Personal Budgeting and Investment Forecasting Tools. Unlock your investment potential today at MyMI Wallet.
mymiwallet.com
Empower your finances with our Personal Budgeting and Investment Forecasting Tools. Unlock your investment potential today at MyMI Wallet.
mymiwallet.com
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Tim Burks | Founder - MyMI Wallet
Empower your finances with our Personal Budgeting and Investment Forecasting Tools. Unlock your investment potential today at MyMI Wallet.
mymiwallet.com
Empower your finances with our Personal Budgeting and Investment Forecasting Tools. Unlock your investment potential today at MyMI Wallet.
mymiwallet.com
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.